Recombinant Human GPR78 Protein，His & GST

GPR78, also known as the Glucosylation-Dependent Receptor 78, is a member of the G protein-coupled receptor (GPCR) family, which plays a crucial role in various physiological processes, including cell signaling, immune response, and metabolism. Studies have shown that GPR78 is involved in the regulation of glucose homeostasis and has potential implications in metabolic disorders such as obesity and diabetes. This receptor participates in the endoplasmic reticulum stress response and is implicated in the pathological mechanisms of several diseases, including cancer and neurodegenerative disorders. The exploration of GPR78 recombinant proteins has garnered significant interest due to their potential as therapeutic targets and tools for understanding GPCR signaling pathways. By producing and characterizing recombinant GPR78, researchers aim to elucidate its structural and functional properties, enhance drug discovery efforts, and develop novel therapeutics that can modulate its activity effectively. Experimental studies focusing on GPR78 recombinant proteins can provide insights into the receptor's ligand binding, activation mechanisms, and downstream signaling pathways, paving the way for innovative approaches to treat GPR78-related diseases and conditions. As a result, the research on GPR78 recombinant proteins not only contributes to the foundational knowledge of GPCR biology but also holds promise for developing targeted therapies that address the growing prevalence of metabolic and neurodegenerative diseases.